Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R10 - February 18, 2025

Date Posted: April 25, 2025

This Billing and Coding Article has been revised under contractor numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: February 18, 2025

Summary of Changes:

Under Article Text revised subheading Additional Test-specific Indications, Limitations and Instructions (2) added "Non-small cell lung cancer (NSCLC) (Natera)." This revision is due to covered test that has successfully completed a TA and is effective for 2/18/2025.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )